Prostate Cancer - Results from #27440

Editor's Commentary - Critical assessment of the European Association of Urology guideline indications for pelvic lymph node dissection at radical prostatectomy July 21, 2011

Screening for prostate cancer with PSA testing: Current status and future directions - Abstract July 20, 2011

Evolving therapeutic paradigms for advanced prostate cancer - Abstract July 20, 2011

Epigenetics in prostate cancer: Biologic and clinical relevance - Abstract July 20, 2011

Early continence in patients with localized prostate cancer. A comparison between open retropubic (RRPE) and endoscopic extraperitoneal radical prostatectomy (EERPE) - Abstract July 20, 2011

Tumor volume, surgical margin, and the risk of biochemical recurrence in men with organ-confined prostate cancer - Abstract July 20, 2011

Impact of marital status and race on outcomes of patients enrolled in Radiation Therapy Oncology Group prostate cancer trials - Abstract July 20, 2011

Internal radiotherapy techniques using radiolanthanide praseodymium-142: A review of production routes, brachytherapy, unsealed source therapy - Abstract July 20, 2011

Information needs of patients with prostate cancer : Pronounced differences between individuals after diagnosis of localised prostate carcinoma - Abstract July 20, 2011

Benefit assessment by the Federal Joint Committee : Assessment of treatment strategies for low risk prostate cancer - Abstract July 20, 2011

Biopsy and treatment decisions in the initial management of prostate cancer and the role of PCA3; a systematic analysis of expert opinion - Abstract July 20, 2011

Editor's Commentary - Physician assessment of pretreatment functional status: A process-outcomes link July 20, 2011

The impact of nerve sparing on incidence and location of positive surgical margins in radical prostatectomy - Abstract July 19, 2011

Efficacy and safety of short-term genistein intervention in patients with localized prostate cancer prior to radical prostatectomy: A randomized, placebo-controlled, double-blind phase 2 clinical trial - Abstract July 19, 2011

SRD5A polymorphisms and biochemical failure after radical prostatectomy - Abstract July 19, 2011

Evaluating the value of number of cycles of docetaxel and prednisone in men with metastatic castration-resistant prostate cancer - Abstract July 19, 2011

A systematic review of replication studies of prostate cancer susceptibility genetic variants in high-risk men originally identified from genome-wide association studies - Abstract July 19, 2011

Initial high-grade prostatic intraepithelial neoplasia with carcinoma on subsequent prostate needle biopsy: Findings at radical prostatectomy - Abstract July 19, 2011

Prognostic factors in prostate cancer. Key elements in structured histopathology reporting of radical prostatectomy specimens - Abstract July 19, 2011

Editor's Commentary - A multicenter study of [-2]pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to 10.0 ng/ml prostate specific antigen range July 19, 2011

Page 1373 of 1435